MeiraGTx Holdings PLC
(FRA:328)
€
6.1
-0.2 (-3.17%)
Market Cap: 500.99 Mil
Enterprise Value: 466.77 Mil
PE Ratio: 0
PB Ratio: 5.50
GF Score: 47/100 MeiraGTx Holdings PLC at Barclays Gene Editing & Gene Therapy Summit (Virtual) Transcript
Nov 15, 2021 / 07:00PM GMT
Release Date Price:
€17
(-0.58%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Good afternoon, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. Welcome to our Fifth Gene Editing & Gene Therapy Summit. It is my great pleasure to introduce our next speaker, Zandy Forbes, President and Chief Executive Officer from MeiraGTx. Zandy, I'll hand over to you.
Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director
Thank you, Gena. Thanks for inviting us to speak at your conference. And I think the format is today, I'm going to do a quick overview of the company, 5, 10 minutes. And then we're going to have questions and answers. Is that correct?
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Yes, that's correct.
Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director
Perfect. So for that quick summary of the company, I'm going to share a slide, just 1 slide, which sort of shows the whole company laid
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot